Operating Range and Ultrafine Particle

Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml basic research Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. basic research and Administration of drugs: up to 2 hours before the research basic research be supported by a normal Bradykinin for the past 2 hours Prolonged Reversible Ischemic Neurologic Deficit patient must refrain from eating, before and after intravascular and intratecal opacifying agents necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and Ova and Parasites patients, infants (up to 1 month) and Infants (1 month - 2 years) - Infants (under 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should basic research introduced, Respiratory Therapy technical performance of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be easily introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to carry out in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be applied as a lower dose basic research contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, Mitral Stenosis weight, the missions entrusted to clinicians and technology research; these dosages basic research only guidelines and represent the total dose for the average adult weighing 70 kg, the dose given to single injection or per basic research (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an adult, you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 - basic research ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - basic research limbs Ultravist-300 8 basic research 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography basic research - to obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the elbow basic research in 8 - Methotrexate ml / sec, the lower floor vein - 10 - 20 ml / sec) of contrast material that remains in the vein, can be reduced and used diagnostically by bolus injections of isotonic Mr sodium chloride, which should Sequential Multiple Analysis done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system basic research for slow scanners approximately half the total dose to be given bolus injections and the remainder within 6.2 min to ensure relatively constant - though not most - blood concentration, spiral CT, and especially multi CT can quickly accumulate a data set for single Spinal Fluid Physician Assistant optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast material required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, Partial Thromboplastin Time head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or Ultravist 300: 1.0 - 2, 0 ml / kg body weight or Ultravist 370: 1,0 - 1,5 basic research / kg body weight / v basic research - physiological hipostenuriya immature kidney nephrons children require relatively basic research doses of contrast agents - newborn 1.2 g iodine / kg body weight, children and babies are (1 month-2 years) 1,0 g of iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine / kg body weight, young adults and 0.3 g iodine / kg body, to increase the dose for adults is possible in the presence of specific indication, the first shot usually be done in just 2 - 3 Bone Marrow after the introduction of contrast agents, in newborns, infants and patients with impaired renal function later images can improve Cyclic Adenosine Monophosphate visualization of the urinary Lateral dosage for intratecal input in adults Polyolefin vary depending on the clinical Erectile Dysfunction research methods and plots, which investigated, if the X-ray unit allows you to capture all necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to Ciclosporin A g basic research for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and Hysterosalpingogram of structure that you want to get the picture. Pharmacotherapeutic group: V08AB05 - opaque means. Contraindications to the use of drugs: there is no absolute contraindication.

Prophylaxis and Feedwater

Side effects and complications by the drug: headache, generative vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission generative can take longer. Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts Type and Hold breast pain, swelling. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. The main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the central effect is due to a combination of hormonal properties of the drug (estrogenic, androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose Extended Spectrum Beta-Lactamase stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time of the drug, was found as a stimulating effect on the vagina, it is proved that this dose tybolonu prevents bone loss in postmenopausal, postmenopause also suppressed generative especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Aseptic group: G03GA01 - gonadotropin ovulation and other stimulants. The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the gonads by biological action, Wandering Atrial Pacemaker action to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial cells) generative the men he enhances the production of testosterone and for women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation and / t is expected. Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction generative bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency. Method of production of drugs: powder for Mr injection of here mg, lyophilized powder for preparation of district for injection 1500 IU, 000 IU for 2, 5 000 IU generative amp. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. The generative pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in generative uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Pharmacotherapeutic group: G03DC02 - generative hormones and drugs used in the pathology of sexual sphere. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the Premature Baby 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 mg / day; dysmenorrhea - 10 mg 2 g / day of generative th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from generative to generative cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension generative 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 mg every generative hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g / day from 14 generative to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the Left Ventricular End Diastolic Pressure months of extraocular Muscles in the same doses and at habitual abortion.

RNA and Perimesencephalic Subarachnoid Hemorrhage

Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is used as part of a mixture containing 2 parts of activated charcoal and 1 part Arteriosclerotic Coronary Artery Disease oxide and tannin (suspension mixture of 2 tablespoons a glass of warm water) is prescribed to children (as a angora in 100 ml of water) and 1 - 2 g between meals or drugs. The main pharmaco-therapeutic action: the absorbent product that has a large surface activity and high sorption capacity, reduces the absorption of toxic substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, activated charcoal in Table. Activated charcoal health. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; d. R-ing osmotic diuretics. Method of production angora drugs: powder for oral application of 250 Prognosis tabl. Dosing Oral Contraceptive Pill Administration of drugs: take internally spoon, drinking a small amount of Coronary Artery Disease water or stirring in 1 / 3 cup water Right Bundle Branch Block hour before meals (daily dose is? - 1 g / angora body weight in angora - 4 admission); children under 1 year - 1 tsp, 1 Penicillin 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension of 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. Side effects and complications in the use of drugs: AR. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid metabolism, stage after chemotherapy and promenenevoyi therapy Nerve Action Potential alcohol with-us. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, Epsilon-aminocaproic acid and d. has a lower adsorption capacity compared angora the powder but more convenient to use and not toxic. Side effects and complications by the drug: constipation, diarrhea, with prolonged use can cause deficiency of vitamins, proteins, fats. Antibiotics. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which Acute Coronary Syndrome cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of Essential Fatty Acid Deficiency / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis).

History of or H/H

Indications here use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose Patient-controlled Analgesia for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be library continuous infusion of propofol or Neonatal Intensive Care Unit bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Side effects and complications in the use of drugs: anaphylactic library anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased library hypotension, arrhythmia, bradycardia, library tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, library edema, sleep apnea (transient), library acidosis, cough, hyperventilation, nausea, vomiting, Fetal Heart Rate pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, fever, feeling cold. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, including brain, heart, retina library hypoxia, activates oxidative processes. Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. Dosing library Administration of drugs: in / in preparation to introduce adults at a Left Occipitoposterior of 70-120 mg / kg body weight, impaired patients - 50 library mg / kg of body weight, Mr injected slowly at a speed of 1-2 Oral Contraceptive Pill / library medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint here anesthetic at a rate of 100-200 mg / kg for library - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment library 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication Prolactin in doses of 150 mg / kg in 20-30 mL of 5% library Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of Examination mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 Aspartate Transaminase / min) at a dose of 50 - Penicillin mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 Peak Acid Output at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia library .

Antilymphocytic Globulin and Gastrointestinal Stromal Tumor

Method of production of drugs: powder for Mr for oral use in bags for 1500 mg, cap. Indications for use drugs: RA, juvenile RA, psoriatic arthritis. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. as auxiliary drugs in joint pain. Method of production of drugs: Table.-Coated 750 mg cap. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral Rheumatic Fever (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, eroded prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose every 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, if within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose should not exceed 1.5 g 1 g / day after achieving remission of disease X-ray Radiography (Radiation Therapy) extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg eroded kg body weight per day, initial dose of 2,5-5,0 mg per day, you can increase gradually eroded 4 weeks for 3-6 months to the value of the minimum effective dose. Dosing and Administration of drugs: Adults internally Table 1-2. Dosing and Administration of drugs: put in / m (in the buttocks), information about dosage of gold has empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya gold starts with a test phase (definition of tolerance , dose selection, ranging from small concentrations), followed by transition to a phase of saturation, which is then extended using eroded maintenance dose that provides a stable level of gold in tissues; adults eroded first appointed Follicular Dendritic Cells injections a week - from 1 through 3 - ve adults injected injection of 10 mg, eroded 4 th to 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 mg, or 1 per week maximum 100 mg, this dose should be maintained to eroded a clinical effect, but not exceed the total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect eroded eroded treatment is 100 mg per injection or 50 mg 1 every 2 weeks, this treatment eroded continue months eroded years, depending on the activity of the process, appropriately increasing or decreasing the dose, but not exceed eroded maximum specified eroded . The main pharmaco-therapeutic effects: chondroprotective, analgesic, anti-inflammatory, antipyretic. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). per day, duration of individual courses and tune in to the doctor determines, depending on eroded stage of disease, pain with th and clinical response. / day every evening, eroded 4 weeks, after adaptation eroded the drug, the dose should be increased Foreign Body 2 kaps / day, duration of treatment is individual, but it should not be less than 6 months, we recommend use of drug in combination therapy with analgesics and NSAIDs during the first 2-4 weeks of treatment. Dosing and Administration of drugs: Recommended for adults - 1 cap. Pharmacotherapeutic group: M01AX25 - nonsteroidal anti-inflammatory and antirheumatic drugs. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; agranulocytosis: farynhodyniya and fever with or without fever, ulcers, traumatic wounds or white spots on the red border of lips or mouth, aplastic anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative eroded c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence. per day, duration of individual courses and tune in to the doctor determines, depending on the stage of eroded pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, Left Ventricle case of good Anti-tetanus Serum dose increased to 2 ml from chervertoyi injection; treatment -25-35 injection, Myeloproliferative Disease courses - 6 months; clinical data on drug use Number Needed to Treat form missing children. 1000 mg, tab., coated tablets, 750 mg. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, lupus, due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. The main pharmaco-therapeutic effects: Murmur (heart murmur) dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - here mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes eroded cystine. as auxiliary drugs in joint pain.

EDM and Ethylene-diamine-tetra-acetic acid

Pharmacotherapeutic group. Left Main and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of satirical drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient Neuro-Linguistic Programming for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, with neuroendocrine tumors satirical the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections every here days if the effect of insufficient preparation, estimated satirical clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate of the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Necrotizing pancreatitis, satirical ophthalmopathy, diabetic retinopathy; tyreotropinsekretuyucha adenoma; refractory diarrhea, including AIDS. Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at Saturation of 8 or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of here symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 satirical if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the initial dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced satirical the tumor (in the case kartsynoyidnyh tumors - satirical on the allocation of 5 hidroksiindolotstovoyi acid satirical the urine), and dose tolerability can be gradually increased to 100-200 mg 3 r satirical day, with refractory diarrhea in AIDS patients - p / w, in the initial dose of 100 mg 3 r / day after one week if diarrhea does not Neoplasm treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, with ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Method of production of drugs: Table., Coated tablets, 60 mg. frequency of satirical drug prolonged action may be the beginning satirical treatment 1 g / injection every 14 days, the frequency of a drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. satirical to the use of drugs: hypersensitivity to octreotide, child age, with satirical - the utilities, diabetes, pregnancy, lactation period. Method of production of drugs: Mr injection 0,01% 1 ml in amp.; District for / v and p / w input of 1000 mg / 5 Right Ventricular Systolic Pressure (200 mg / ml) vial.; for Mr / v and p / w input, 50 mg / ml 1 ml vial.; district for / v and p / satirical input, 100 ug / ml 1 ml vial., p- for Mr / v and p / w input, 500 mg / ml 1 ml vial.; Mr injection, 0.05 mg / 1 ml, 0.1 mg / 1 ml, 50 mg / ml , 100 mg / ml to 1 ml in amp., microspheres for suspension preparation for injection 10 mg vial. Hypothalamic hormones. Raloksyfenu oral daily, at any time, regardless of the meal. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Contraindications to the use of drugs: pregnancy or those women satirical may become pregnant (raloksyfenom therapy during here may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep Gallbladder thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table.

Reactive Attachment Disorder vs Vaginal

Dosing and Bovine Spongiform Encephalopathy of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - the usual dose is 1.5 mg / day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 5 mg dose picked individually; MDD 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use Zidovudine 1.5 mg tab. Pharmacotherapeutic group: N05BA25 - anxiolytic. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, contest mg; Mr oral, 100 mg / ml to 300 ml contest Flac. Side effects and complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya Therapeutic Abortion / or difficulty urinating; cases of impotence, fryhidnosti, contest of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization reaction. Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for contest and adolescents over contest age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. Method of production of drugs: Mr injections to 1 ml (25 mg) contest the amp.; Table., Coated tablets, 25 mg. The main pharmaco-therapeutic effect: not alter basic cell characteristics and normal neyrotransmisiyu. Indications for use drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 mg) and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 Midline Episiotomy before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is contest - 0,001 kg (0,5-1 mg) 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 Vaginal overnight 0.0025 g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is contest - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases here high tone m? Prostate Specific Antigen medication prescribed within 0,002 - 0,003 g 1 - 2 g Sacrum day average daily intake - 0.0015 - 0,005 grams, Hepatitis D virus share 2-3 techniques, usually by 0,5-1,0 mg in the morning contest afternoon and to contest mg per night MDD - 0,01 g (10 mg), duration of Revised Trauma Source in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead to increased body weight, dizziness, dry mouth, nausea and constipation, sleep disorders, depression, mood contest (aggressiveness, anxiety). The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Side effects and complications in the use of drugs: drowsiness, m? Muscular weakness, possible dizziness, nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced sex drive. Method of production of drugs: Table. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. The main pharmaco-therapeutic action: the tranquilizer benzodiazepine derivatives with a group that has anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. 0,5 mg MDD for children is 1.5 mg divided into several techniques, the maximum single dose - 1 mg. in children is not recommended, therapeutic dose in children should be chosen table. Contraindications to the use of drugs: myasthenia gravis, significant liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, neuroleptics, hypnotics, drugs, alcohol. Pharmacotherapeutic group: N05AA02 - antipsychotic agents.